Tatva Chintan Pharma Chem Limited has announced the closure of its trading window for dealing in the company's securities. This closure is in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code on insider trading. The trading window will be shut for all Designated Persons and their immediate relatives starting from Thursday, January 1, 2026. This closure will remain in effect until 48 hours after the declaration of the company's Unaudited Financial Results for the quarter and nine months ending December 31, 2025. Consequently, all Designated Persons and their immediate relatives have been advised against trading in the company's securities during this period. The company has informed BSE Limited and the National Stock Exchange of India Limited about this development.